CELYAD ONCOLOGY Stock Was 10.76% Up Today
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) jumping 10.76% to €0.84 on Monday while BEL 20 jumped 0.78% to €3,630.99. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead…